Novel silver(I)N-heterocyclic carbene complexes bearing 2-(4-hydroxyphenyl)ethyl group: Synthesis, characterization, and enzyme inhibition properties

dc.contributor.authorBehcet, Ayten
dc.contributor.authorAktas, Aydin
dc.contributor.authorGok, Yetkin
dc.contributor.authorKaya, Ruya
dc.contributor.authorTaslimi, Parham
dc.contributor.authorGülçin, İlhami
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T10:10:35Z
dc.date.created2020
dc.date.issued2020
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractHerein, novel silver-based N-heterocyclic carbene (NHC) complexes bearing 2-(4-hydroxyphenyl)ethyl group were synthesized. Novel Ag(I)NHC complexes were synthesized from the 2-(4-hydroxyphenyl)ethyl-substituted benzimidazolium salts and silver oxide via in situ deprotonation method. The successful formation of all Ag(I)NHC complexes was proved by using H-1 NMR, C-13 NMR, FTIR spectroscopy, and elemental analysis techniques. In addition, their inhibitory effects have been investigated of these substances on acetylcholinesterase (AChE), alpha-glycosidase (alpha-Gly), human carbonic anhydrase I (hCA I), and human carbonic anhydrase II (hCA II) enzymes. It has been seen that all compounds have a better ability to inhibit compared with existing tried inhibitors. Among these, the best inhibitor against AChE enzyme is 1g (K-i : 9.54 +/- 0.98 mu M and IC50 : 17.40), and against alpha-Gly, 1c showed the highest effect (K-i 3.09 +/- 0.36 mu M and IC50 7.91). The best inhibitor against hCA I and hCA II enzymes are 1c and 1g compounds. For hCA I and hCA II, IC50 values were calculated as 17.85 and 9.06 mu M and K-i values were measured as 5.45 +/- 2.02 and 8.99 +/- 2.02 mu M, respectively.
dc.description.sponsorshipInonu Universitesi [FYL-2018-1431]
dc.description.sponsorshipInonu Universitesi, Grant/Award Number: FYL-2018-1431
dc.identifier.doi10.1002/jhet.4199
dc.identifier.endpage611
dc.identifier.issn0022-152X
dc.identifier.issn1943-5193
dc.identifier.issue2
dc.identifier.orcidAktas, Aydin/0000-0001-8496-6782
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcidGulcin, ilhami/0000-0001-5993-1668;
dc.identifier.scopus2-s2.0-85097289926
dc.identifier.scopusqualityQ3
dc.identifier.startpage603
dc.identifier.urihttps://doi.org/10.1002/jhet.4199
dc.identifier.urihttps://hdl.handle.net/11772/21944
dc.identifier.volume58
dc.identifier.wosWOS:000596501200001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Heterocyclic Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectN-Heterocyclic Carbenes
dc.subjectNatural-Products Synthesis
dc.subjectPotential Antitumor-Activity
dc.subjectCrystal-Structure
dc.subjectCarbonic-Anhydrase
dc.subjectCatalytic-Activity
dc.subjectCorresponding Gold(I)
dc.subjectBenzimidazolium Salts
dc.subjectIn-Vitro
dc.subjectDerivatives
dc.titleNovel silver(I)N-heterocyclic carbene complexes bearing 2-(4-hydroxyphenyl)ethyl group: Synthesis, characterization, and enzyme inhibition properties
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar